In addition to that, silencing of RASSF1 gene expression has been linked to de novo hypermethylation; RASSF1 hypermethylation has previously been found in human tumours, including liver cancer30, indicating the HIGH dose of E2 as potential cancer-inducing risk factor. This evidence concerns the gene RASSF1 and neoplasm.